Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Decazes

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Radiation Oncology (London, England)|May 24, 2020
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancerRomain Mallet, Romain Modzelewski, Justine Lequesne, et al.
Diagnostics (Basel, Switzerland)|January 21, 2023
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic DrugsPierre Decazes, Samy Ammari, Antoine De Prévia, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2026
Clinical value of per-treatment whole-body single-time-point automated dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancerArnaud Dieudonné, Aya Terro, Arthur Dumouchel, et al.
EJNMMI Research|October 8, 2020
Correlations between baseline <sup>18</sup>F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphomaPierre Decazes, Vincent Camus, Elodie Bohers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2019
Radiotherapy boost in patients with hypoxic lesions identified by <sup>18</sup>F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]Pierre Vera, Sorina-Dana Mihailescu, Justine Lequesne, et al.
Biomolecules|March 25, 2020
Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid TumoursBenjamin Poret, Laurence Desrues, Marc-André Bonin, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 8, 2021
Deep neural network for automatic volumetric segmentation of whole-body CT images for body composition assessmentYoon Seong Lee, Namki Hong, Joseph Nathanael Witanto, et al.
EJNMMI Research|July 1, 2026
Automatic lesion segmentation in ⁶⁸Ga-PSMA PET/CT and ¹⁷⁷Lu-PSMA SPECT/CT: added value of PET-guided SPECT in a bicentric studySolène Perret, Léa Albe, Agathe Edet-Sanson, et al.
Journal for Immunotherapy of Cancer|September 7, 2023
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancerPierre Decazes, Samy Ammari, Younes Belkouchi, et al.
EJNMMI Research|May 27, 2024
Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective studyDavid Morland, Lukshe Kanagaratnam, Fabrice Hubelé, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Radiation Oncology (London, England)|May 24, 2020
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancerRomain Mallet, Romain Modzelewski, Justine Lequesne, et al.
Diagnostics (Basel, Switzerland)|January 21, 2023
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic DrugsPierre Decazes, Samy Ammari, Antoine De Prévia, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2026
Clinical value of per-treatment whole-body single-time-point automated dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancerArnaud Dieudonné, Aya Terro, Arthur Dumouchel, et al.
EJNMMI Research|October 8, 2020
Correlations between baseline <sup>18</sup>F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphomaPierre Decazes, Vincent Camus, Elodie Bohers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2019
Radiotherapy boost in patients with hypoxic lesions identified by <sup>18</sup>F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]Pierre Vera, Sorina-Dana Mihailescu, Justine Lequesne, et al.
Biomolecules|March 25, 2020
Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid TumoursBenjamin Poret, Laurence Desrues, Marc-André Bonin, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 8, 2021
Deep neural network for automatic volumetric segmentation of whole-body CT images for body composition assessmentYoon Seong Lee, Namki Hong, Joseph Nathanael Witanto, et al.
EJNMMI Research|July 1, 2026
Automatic lesion segmentation in ⁶⁸Ga-PSMA PET/CT and ¹⁷⁷Lu-PSMA SPECT/CT: added value of PET-guided SPECT in a bicentric studySolène Perret, Léa Albe, Agathe Edet-Sanson, et al.
Journal for Immunotherapy of Cancer|September 7, 2023
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancerPierre Decazes, Samy Ammari, Younes Belkouchi, et al.
EJNMMI Research|May 27, 2024
Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective studyDavid Morland, Lukshe Kanagaratnam, Fabrice Hubelé, et al.
Pageof 6